Thromboelastography Machine Market Analysis Revealing Key Drivers, Growth Trends and Competitive Assessment through 2026

Thromboelastography (TEG) is a viscoelastic hemostatic assay that measures the visco-elastic properties of blood clot formation. It is mainly used in surgery and anesthesiology. These tests are capable of measuring coagulation factor function. Some other tests for blood coagulation includes prothrombin time (PT,INR) and partial thromboplastin time (aPTT). However, thromboelastography provides information regarding all components of hemostasis such as coagulation and platelet function. Also, TEG offers a particular advantage in diagnosing fibrinolysis. TEG machines are used for carrying out this test.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/2371

Increasing use of TEG machines for blood management has helped in predicting and managing bleeding disorders. It also helps in evaluating the risk for re-operation, which leads to cost saving, as it reduces unnecessary blood component transfusions. These machines have applications in hospitals, blood banks, pharmaceutical, and academic institutes.

Thromboelastography Machine Market – Dynamics

Increasing patient population suffering from lifestyle associated diseases and chronic blood disorder is expected to contribute to significant growth of the thromboelastography machine market. For instance, according to the Leukemia & Lymphoma Society (LLS), about every 3 minutes, one person is diagnosed with blood cancer, which accounted for combined total of 174,250 people in the U.S. in 2017. Moreover, around 1,735,350 new cancer cases are expected to be diagnosed in 2018, which accounts for around 10% of the total U.S. population as per the data given by the Leukemia and Lymphoma society (LLS). Furthermore, rising awareness in the management of acute coagulopathy of trauma is expected to propel growth of the thromboelastography machine market.

Moreover, emergence of high throughput TEG analyzers is propelling the market growth. For instance, in 2017, Haemonetics Corporation received FDA 510(k) approval for its TEG 6s Hemostasis System, which is used to study an individual’s hemostasis condition in a laboratory or in point-of-care setting. However, increasing research activities for the development of substitutes for testing the efficiency of blood coagulation is expected to limit growth of thromboelastography machine market.

Thromboelastography Machine Market – Regional Insights

Based on the region, the global thromboelastography machine market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the global thromboelastography machine market during the forecast period. This is owing to developed healthcare infrastructure and rising R&D activities in the region. Moreover, growing incidence of surgeries and organ transplant procedures is expected to propel growth of the market. For instance, according to U.S. Department of Health and Human Services, 34,770 transplants were performed in the U.S in 2017.

Furthermore, Asia Pacific is expected to witness significant growth in the thromboelastography machine market during the forecast period, owing to rising adoption of TEG analyzers in diagnostic laboratories in this region. Moreover, increasing prevalence of hemostasis disorders has fuelled growth of thromboelastography machine market in this region. For instance, according to the World Federation of Hemophilia annual report, approximately 17,346 people were suffering from Hemophilia in India in 2015.

Thromboelastography Machine Market – Competitive Landscape

Major players operating in the thromboelastography machine markets include Haemonetics Corporation, Life Diagnostica, Hemologix s.r.l., Medirox AB, Instrumentation Laboratory, Diagnostica Stago and others. Key players in thromboelastography machine market are focusing on implementing strategies such as new product launches and acquisitions in order to retain dominant position in the market. For instance, in 2016, Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem). This will help IL in expanding its product line in Hemostasis and Critical Care IVD and in viscoelastic testing.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2371

Thromboelastography Machine Market – Taxonomy

On the basis of types of assays, the global thromboelastography machine market is segmented into:

Standard
RapidTEG
Heparinase
Functional Fibrinogen
Platelet Mapping
Others

On the basis of application, the global thromboelastography machine market is segmented into:

Liver Transplantation
Cardio-pulmonary Bypass Surgery
Obstetrics
Neonatology and Pediatrics
Trauma
Others

On the basis of end user, the global thromboelastography machine market is segmented into:

Hospitals & Clinics
Academic Institutes
Blood Banks
Others

On the basis of geography, the global thromboelastography machine market is segmented into:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.